Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Minjuvi

MINJUVI 200 mg powder for concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 10

HOS-147419 · Präparat HOS-099656

Infections and infestations Viral infectionsb Very common Very common Bacterial infectionsc Very common Common Pneumonia Very common Common Bronchitis Common - Sepsis Common Uncommon Blood and lymphatic system disorders Neutropeniad Very common Very common Thrombocytopeniae Very common Common f Anaemia Very common Common Febrile neutropenia Common Common Leukopenia Common Uncommon Metabolism and nutrition disorders Tumour lysis syndrome Uncommon Uncommon Nervous system disorders Headache Very common Uncommon Gastrointestinal disorders Diarrhoea Very common Uncommon Constipation Very common Uncommon Abdominal paing Very common - Skin and subcutaneous tissue disorders Rashh Very common Common Pruritus Very common Uncommon General disorders and administration site conditions Astheniai Very common Common Pyrexia Very common Common Chills Common - Investigations ALT increased Common Uncommon AST increased Common Uncommon Injury, poisoning, and procedural complications Infusionrelated reaction Very common Uncommon a The severity of adverse drug reactions was assessed based on the CTCAE, defining grade 1 = mild, grade 2 = moderate, grade 3 = severe, grade 4=life threatening, and 5=death. b Includes viral infection, COVID-19, COVID-19 pneumonia, coronavirus infection, coronavirus test positive, cytomegalovirus chorioretinitis, cytomegalovirus infection reactivation, gastroenteritis rotavirus, genital herpes, Hepatitis B, herpes ophthalmic, herpes simplex, herpes simplex reactivation, herpes virus infection, herpes zoster, herpes zoster reactivation, influenza, laryngitis viral, nasal herpes, norovirus infection, oral herpes, parainfluenzae virus infection, pneumonia viral, progressive multifocal leukoencephalopathy, respiratory syncytial virus infection, respirovirus test positive, rhinovirus infection, skin papilloma, varicella zoster pneumonia, varicella zoster virus infection, and viral upper respiratory tract infection. c Includes bacterial infection, abdominal infection, abscess, appendicitis, asymptomatic bacteriuria, atypical pneumonia, bacteraemia, bacterial sepsis, breast abscess, bronchopulmonary aspergillosis, campylobacter gastroenteritis, campylobacter infection, carbuncle, catheter site infection, cellulitis, cholecystitis, chronic sinusitis, clostridium difficile colitis, clostridium difficile infection, corynebacterium infection, device related infection, diverticulitis, ear infection, ear lobe infection, empyema, enterobacter bacteraemia, erysipelas, erythrasma, escherichia infection, escherichia sepsis, eye infection, folliculitis, furuncle, hemophilus bacteraemia, hemophilus infection, helicobacter gastritis, helicobacter infection, infected cyst, infected dermal cyst, lower respiratory tract infection, moraxella infection, mycobacterium chelonae infection, myopericarditis, myringitis, otitis externa, otitis media, perineal infection, periodontitis, peritonitis bacterial, pneumocystis jirovecii pneumonia, pneumonia moraxella, pneumonia pneumococcal, pneumonia streptococcal, postoperative wound infection, proctitis, prostatitis,

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.